Known targets — ChEMBL curated mechanism
ACHESCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9A
The experimentally established mechanism targets of Gluconic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.87 |
| ▸ | PDE4A | P27815 | 1/20 | 0.64 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.48 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | CA4 | P22748 | 2/20 | 0.31 |
| ▸ | TOP1 | P11387 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Gluconic Acid SCHEMBL1565178 | 1.00 | LMNA (0.87) | LMNAPDE4AL3MBTL1USP2SLCO1B1 | |
| Gluconic Acid SCHEMBL721131 | 1.00 | LMNA (0.87) | LMNAPDE4AL3MBTL1USP2SLCO1B1 | |
| Gluconic Acid SCHEMBL19585112 | 1.00 | LMNA (0.87) | LMNAPDE4AL3MBTL1USP2SLCO1B1 | |
| Gluconic Acid SCHEMBL22442432 | 1.00 | LMNA (0.87) | LMNAPDE4AL3MBTL1USP2SLCO1B1 | |
| Gluconic Acid SCHEMBL7265130 | 1.00 | LMNA (0.87) | LMNAPDE4AL3MBTL1USP2SLCO1B1 | |
| Gluconic Acid SCHEMBL9456606 | 0.98 | LMNA (0.91) | LMNAPDE4AL3MBTL1USP2SLCO1B1 | |
| Gluconic Acid SCHEMBL161222 | 0.98 | LMNA (0.91) | LMNAPDE4AL3MBTL1USP2SLCO1B1 | |
| Gluconic Acid SCHEMBL35424 | 0.98 | LMNA (0.91) | LMNAPDE4AL3MBTL1USP2SLCO1B1 | |
| Gluconic Acid SCHEMBL3768836 | 0.98 | LMNA (0.91) | LMNAPDE4AL3MBTL1USP2SLCO1B1 | |
| Gluconic Acid SCHEMBL23566696 | 0.95 | LMNA (0.87) | LMNAPDE4AL3MBTL1USP2SLCO1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024258187-A1 | COMPOSITION FOR STRENGTHENING HAIR ROOTS COMPRISING METAL-PHENOLIC COMPLEX AND MELANIN OR PRECURSOR THEREOF | 코스맥스 주식회사 | 2024-12-19 | — | — | WO | claimed |
| CN-116359391-A | Detection method of sulfonamide antibiotics in soil and sample treatment method thereof | 浙江省农业科学院 | 2023-06-30 | — | — | CN | claimed |
| US-11597863-B2 | Methods of cementing a wellbore | BAKER HUGHES OILFIELD OPERATIONS LLC (US) | 2023-03-07 | — | — | US | claimed |
| WO-2020190956-A1 | METHODS OF CEMENTING A WELLBORE | BAKER HUGHES OILFIELD OPERATIONS LLC (US) | 2020-09-24 | — | — | WO | claimed |
| US-20200299563-A1 | METHODS OF CEMENTING A WELLBORE | BAKER HUGHES OILFIELD OPERATIONS LLC (US) | 2020-09-24 | — | — | US | claimed |
| WO-2024258193-A1 | METAL-PHENOL COMPLEX AND DYEING COMPOSITION COMPRISING MELANIN OR PRECURSOR THEREOF | 코스맥스 주식회사 | 2024-12-19 | — | — | WO | disclosed |
| WO-2024258183-A1 | SKIN SOOTHING OR ANTI-INFLAMMATORY COMPOSITION COMPRISING METAL-PHENOLIC COMPLEX AND MELANIN OR PRECURSOR THEREOF | 코스맥스 주식회사 | 2024-12-19 | — | — | WO | disclosed |
| WO-2024258187-A1 | COMPOSITION FOR STRENGTHENING HAIR ROOTS COMPRISING METAL-PHENOLIC COMPLEX AND MELANIN OR PRECURSOR THEREOF | 코스맥스 주식회사 | 2024-12-19 | — | — | WO | disclosed |
| WO-2024258190-A1 | HAIR DYE COMPOSITION FOR PREMATURE GRAY HAIR AND METHOD FOR PREPARING SAME | 코스맥스 주식회사 | 2024-12-19 | — | — | WO | disclosed |
| CN-116359391-A | Detection method of sulfonamide antibiotics in soil and sample treatment method thereof | 浙江省农业科学院 | 2023-06-30 | — | — | CN | disclosed |
| US-11597863-B2 | Methods of cementing a wellbore | BAKER HUGHES OILFIELD OPERATIONS LLC (US) | 2023-03-07 | — | — | US | disclosed |
| CN-115429899-A | Method for producing reagent and reagent produced by the production method | 牛尾电机(苏州)有限公司 | 2022-12-06 | — | — | CN | disclosed |
| WO-2007035886-A1 | NATURAL BIODEGRADABLE MATRICES AND USES THEREOF | SURMODICS, INC. (US) | 2007-03-29 | — | — | WO | disclosed |
| US-20070071792-A1 | In VIVO formed matrices including natural biodegradale polysaccharides and ophthalmic uses thereof | SURMODICS MD, LLC | 2007-03-29 | — | — | US | disclosed |
| WO-2007035865-A1 | COATINGS AND ARTICLES INCLUDING NATURAL BIODEGRADABLE POLYSACCHARIDES | SURMODICS, INC. (US) | 2007-03-29 | — | — | WO | disclosed |
| US-20070065484-A1 | In situ occlusion using natural biodegradable polysaccharides | SURMODICS MD, LLC | 2007-03-22 | — | — | US | disclosed |
| US-20070065481-A1 | Coatings including natural biodegradable polysaccharides and uses thereof | SURMODICS MD, LLC | 2007-03-22 | — | — | US | disclosed |
| US-20070065483-A1 | In vivo formed matrices including natural biodegradable polysaccharides and uses thereof | SURMODICS MD, LLC | 2007-03-22 | — | — | US | disclosed |
| US-20070065482-A1 | Articles including natural biodegradable polysaccharides and uses thereof | SURMODICS MD, LLC | 2007-03-22 | — | — | US | disclosed |
| US-20050154146-A1 | Process for the preparation of iron ion containing water-absorbent polymers with low residual monomer content | DOW GLOBAL TECHNOLOGIES INC. | 2005-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070065481-A1 | Coatings including natural biodegradable polysaccharides and uses thereof | FUT6, FUT5, CD44 | LMNA 3532/4885PDE4A 2149/4885L3MBTL1 3141/4885 |
| US-20070065482-A1 | Articles including natural biodegradable polysaccharides and uses thereof | CD44, FUT6, FGF23 | LMNA 3763/4885PDE4A 1284/4885L3MBTL1 3118/4885 |
| US-20070065483-A1 | In vivo formed matrices including natural biodegradable polysaccharides and uses thereof | CD44, ADAMTS4, BMP2 | LMNA 1063/4885PDE4A 1101/4885L3MBTL1 2023/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.